References
- DarsowURaapUStänderSRCarstensEAkiyamaTItch: Mechanisms and TreatmentBoca RatonCRC Press2014832836
- RingJPrzybillaBRuzickaTHandbook of atopic eczema2nd edNew YorkSpringer-Verlag Berlin Heidelberg2006
- FriedmmanPSHoldenCAAtopic dermatitisBurnsTBreathnachSCoxNGriffithsCRook’s Textbook of Dermatology7th edOxford, EnglandBlackwell Sciences2008755786
- CharmanCClinical evidence: atopic eczemaBMJ199931871981600160410364122
- SudilovskyAMuirJGBocoboFCA comparison of single and multiple applications of halcinonide creamInt J Dermatol19812096096137030988
- DarsowULübbeJTaïebAPosition paper on diagnosis and treatment of atopic dermatitisJ Eur Acad Dermatol Venereol200519328629515857453
- HaeckIMRouwenTJMikLTBruin-WellerMSBruijnzeel-KoomenCATopical corticosteroids in atopic dermatitis and the risk of glaucoma and cataractsJ Am Acad Dermatol201164227528121122943
- HajarTLeshemYAHanifinJMA systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatosesJ Am Acad Dermatol2015723541e549e.e225592622
- O’HaraMKieferDFarrellKKemperKA review of 12 commonly used medicinal herbsArch Fam Med1998765235369821826
- ZhaoJLahiri-ChatterjeeMSharmaYAgarwalRInhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skinCarcinogenesis200021481181610753220
- GazakRWalterovaDKrenVSilybin and silymarin – new and emerging applications in medicineCurr Med Chem200714331533817305535
- SinghRPAgarwalRCosmeceuticals and SilibininClin Dermatol200927547948419695480
- DehmlowCErhardJde GrootHInhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibininHepatology19962347497548666328
- RasulANaveedAAliAAssessment of anti erythmic and skin whitening effects of milk thistle extractAfrican Journal of Pharmacy and Pharmacology20115202023062309
- SvobodováAWalterováDPsotováJInfluence of silymarin and its flavonolignans on H(2)O(2)-induced oxidative stress in human keratinocytes and mouse fibroblastsBurns200632897397917011711
- TokluHZTunalı-AkbayTErkanlGYukselMErcanFSenerGSilymarin, the antioxidant component of Silybum marianum, protects against burn-induced oxidative skin injuryBurns200733790891617521818
- Ashkani-EsfahaniSEmamiYEsmaeilzadehESilymarin enhanced fibroblast proliferation and tissue regeneration in full thickness skin wounds in rat models; a stereological studyJournal of the Saudi Society of Dermatology & Dermatologic Surgery2013171712
- HanMHYoonWKLeeHTopical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c miceInt Immunopharmacol20077131651167817996674
- Becker-SchiebeMMengsUSchaeferMBulittaMHoffmannWTopical use of a silymarin-based preparation to prevent radiodermatitis: results of a prospective study in breast cancer patientsStrahlenther Onkol2011187848549121786113
- GilletALecomteFHubertPDucatEEvrardBPielGSkin penetration behaviour of liposomes as a function of their compositionEur J Pharm and Biopharm2011791435321272638
- JosefEZilbermanMBianco-PeledHComposite alginate hydrogels: An innovative approach for the controlled release of hydrophobic drugsActa Biomater20106124642464920601237
- SpadaGGaviniECossuMRassuGCartaAGiunchediPEvaluation of the effect of hydroxypropyl-β-cyclodextrin on topical administration of milk thistle extractCarbohydr Polym2013921404723218263
- KumarRKatareOPLecithin organogels as a potential phospholipid structured system for topical drug delivery: a reviewAAPS Pharm-SciTech200562E298E310
- ParsaeeSSarboloukiMNParniapourMIn-vitro release of diclofenac dethylammnium from lipid-based formulationsInt J Pharm2002241118519012086734
- PeinzesTCsoikaIErosIRheological analysis of the structural properties effecting the percutaneous absorption and stability in pharmaceutical organogelsRheol Acta200443457463
- BalataGEl NahasHMRadwanSPropolis organogel as a novel topical delivery system for treating woundsDrug Deliv2014211556124295500
- SurjyanarayanMSnigdhaSMKrutikaKSLecithin stabilized organogel: design and development for topical application of clobetasol propionateInt J Pharm Tech Res20102211331138
- StationwalaRPatidarAMainPTransdermal delivery of Iornoxicam from pluronic lecithin organogelInt J Chem Pharm Sci2011223237
- PiscitelliSCFormentiniEBursteinAHAlfaroRJagannathaSFalloonJEffect of milk thistle on the pharmacokinetics of indinavir in healthy volunteersPharmacotherapy200222555155612013352
- JohnsonVJHeQOsuchowskiMFSharmaRPPhysiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: III. Silymarin inhibits T-lymphocyte function at low doses but stimulates inflammatory processes at high dosesPlanta Med2003691444912567278
- KangJSYoonWKHanMHInhibition of atopic dermatitis by topical application of silymarin in NC/Nga miceInt Immunopharmacol20088101475148018593606
- AlmeidaHAmaralMHLobaoPLoboJMPluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugsJ Pharm Pharm Sci201215459260523106961
- BhatiaASinghBRazaKWadhwaSKatareOTamoxifen-loaded lecithin organogel (LO) for topical application: Development, optimization and characterizationInt J Pharm20134441–2475923353077